RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $255 Price Target

RBC Capital analyst Shagun Singh has reiterated an 'Outperform' rating on Johnson & Johnson (NYSE: JNJ) while maintaining a price target of $255 for the stock. This endorsement suggests confidence in the company's performance and potential growth.